TriSalus Life Sciences (TLSI) via MedTech Acq (MTAC) deck
TriSalus Life Sciences® is an oncology therapeutics company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors.